EPA, FDA and USDA Issues Updates to the Joint Regulatory Plan for Biotechnology

Contact Information: EPA Press Office (press@epa.gov) Source: https://www.epa.gov/newsreleases/epa-fda-and-usda-issues-updates-joint-regulatory-plan-biotechnology WASHINGTON – Today, May 8, 2024, in response to President Biden’s Executive Order 14081, “Advancing Biotechnology and Biomanufacturing Innovation for a Sustainable, Safe, and Secure American Bioeconomy,” the U.S. Environmental Protection Agency, the U.S. Food and Drug Administration and the U.S. Department of Agriculture have developed a plan to update, streamline…

Read More

Radyus Research and Dt&CRO Join Forces to Pave Way for South Korean Biotech Companies into the U.S. Market

Source: Radyus/PR Newswire ATLANTA, May 7, 2024 /PRNewswire/ — Radyus Research, a global drug development organization from Atlanta, Georgia, is excited to announce a pivotal strategic partnership with Dt&CRO, a leading South Korean contract research organization (CRO). This collaboration aims to assist South Korean biotech companies in entering the U.S. market by offering integrated services for drug development…

Read More

Atlanta’s Biotech Scene Prepares for New Heights

Source: BioSpace A new project has capped off construction in Midtown Atlanta, providing physical real estate that experts say is sorely needed for the region’s growing biotech ecosystem, now home to more than 4,000 life science companies. KEEP READING AT BIOSPACE HERE.

Read More

Andson Biotech raises $3.6 million seed round

Source: Andson Bio ATLANTA, April 30, 2024 – Andson Biotech, a biotools company developing streamlined sample prep and data analytics solutions for mass spectrometry workflows, has successfully closed a $3.6 million round in equity financing. This capital will support hiring talent to accelerate the market introduction of its inline mass spec sample prep solution, DynaCHIP. This patented technology…

Read More

AdvaMed Statement on the Release of FDA Rule on Laboratory-Developed Tests

WASHINGTON, D.C. – Today, AdvaMed, the Medtech Association, released the following statements from President and CEO Scott Whitaker and Zach Rothstein, Executive Director of AdvaMedDx, on FDA’s final rule for Laboratory Developed Tests (LDTs): “We appreciate FDA’s commitment to ensuring the safety and effectiveness of in vitro diagnostic tests, regardless of their source, which is what today’s rule…

Read More

ClinicalMind Acquires 11TEN Innovation Partners, Uniting Cutting-Edge Medical Communications with Strategic Consulting to Drive Innovation in Life Sciences

NEW YORK, April 23, 2024 /PRNewswire-PRWeb/ — ClinicalMind, LLC (CM), a premier healthcare marketing and communications company, today announced the acquisition of 11TEN Innovation Partners (11TEN), a leading strategy consulting firm with a robust healthcare innovation ecosystem. This strategic move combines CM’s expertise in medical communications and training with 11TEN’s capabilities in commercial strategy and innovation consulting,…

Read More

Georgia Bio and Brex Partner to Enhance Member Benefits

Exciting news for Georgia Bio members! The Georgia Bio Brex program, established through our partnership with BIO, has been expanded to provide even greater benefits for your organization. On top of the existing corporate credit card with its industry-specific rewards, members can now access savings on business accounts, spend management software, and travel management solutions.…

Read More